Morphine for chronic breathlessness (MABEL) in the UK: a health economic evaluation of a multi-site, parallel-group, dose titration, double-blind, randomised, placebo-controlled trial
(2025)
Journal Article
Atter, M. J., Hall, P., Evans, R., Norrie, J., Cohen, J., Williams, B., Chaudhuri, N., Bajwah, S., Higginson, I., Pearson, M., Currow, D., Stewart, G., Fallon, M., & Johnson, M. (2025). Morphine for chronic breathlessness (MABEL) in the UK: a health economic evaluation of a multi-site, parallel-group, dose titration, double-blind, randomised, placebo-controlled trial. BMJ open, 15, e102124. https://doi.org/10.1136/bmjopen-2025-102124
Objectives: To compare costs and health consequences and to assess the cost-effectiveness of using low-dose oral long-acting morphine in people with chronic breathlessness.
Design: Within-trial planned cost-consequences and cost-effectiveness analy...
Read More about Morphine for chronic breathlessness (MABEL) in the UK: a health economic evaluation of a multi-site, parallel-group, dose titration, double-blind, randomised, placebo-controlled trial.